Field of Science

Showing posts with label E. coli. Show all posts
Showing posts with label E. coli. Show all posts

Which E. coli is best?

I haven't yet tested whether different growth/non-growth conditions alter the expression of the ppdA fusion (though I did get the sxy manuscript resubmitted today), but a paper I came across reminded me of another issue I need to consider.

The paper is an opinion piece titled "Laboratory strains of Escherichia coli: model citizens or deceitful delinquents growing old disgracefully?"; it just came out in the journal Molecular Microbiology (Mol. Micb. 64:881-885). The authors argue that the standard K-12-derived strains of E. coli that microbiologists and molecular biologists typically use are not at all representative of the strains out in the natural environment. For one thing, lab strains have lost about 20% of their genomes. These are (by definition) non-essential genes, but their loss no doubt affects cellular metabolism, so that the metabolic interactions we see in K-12 strains may be quite different than those in natural strains. Furthermore, the culture conditions we use (rich broth, lots of oxygen, no competitors) are unlikely to ever occur in nature. Their long maintenance under these and other unnatural conditions means that the lab strains will have evolved by accumulating cryptic mutations that are beneficial under lab culture conditions but that may have very different and perhaps harmful effects in the natural environment.

I already knew this. It has important implications for my search for conditions that induce expression of competence genes in E. coli. Right now I'm working with standard lab strains, but it's all too possible that one of their ancestors lost the ability to express the genes encoding homologs of H. influenzae's competence genes, or to assemble the proteins into functional DNA uptake machinery.

So I should perform my tests on a less lab-adapted, more 'natural' strain as well as on the K-12 strain the ppdA::lacZ fusion is in. But this raises two problems. First, which strain should I use? I do have a fairly-ancestral K-12 strain, but really I should use a 'wild' strain recently isolated from the environment. The NCBI Microbial Genomes page lists 8 completely sequenced E. coli genomes; their sizes range from 4.6 million bp (K-12) to 5.6 million bp (O157:H7). And the various wild strains have genomes that are quite different from each other - does this mean I would need to test many strains before giving up? I'm also not meticulous enough to be trusted with a strain that's seriously pathogenic to humans, so the two O157:H7 strains are out, as is the uropathogenic strain*.

Second, I'll need to transfer the necessary genes into this strain; first a lacZ mutation making it Lac-, then the ppdA::lacZ fusion so I can assay induction by Sxy. This might mean that I need to get my P1 transductions working after all (I had been thinking I could let them slide now that I've found that the ppdA::lacZ fusion can be used as an indicator of CRP-S induction by Sxy). I don't need P1 to move in the ppdA fusion because it's on a plasmid, but transduction would certainly be the easiest way to move a lac- mutation in. If I'm lucky, maybe some of the wild strains are naturally Lac-. (Probably not; most screens for wild E. coli start by treating anything that's Lac- as not E. coli.)

* NCBI also lists 6 sequenced 'Shigella' genomes - we now know that the bacterial strains assigned to the genus Shigella are really variants of E. coli. But I have absolutely no intention of working with these very pathogenic bacteria.

Results of the obvious next step

As I posted a few days ago, I planned to introduce a sxy-expression plasmid into my cells with CRP-S promoter fusions to lacZ, to see if the CRP-S promoters are indeed induced by Sxy. I did that yesterday, and I just finished calculating the amounts of beta-galactosidase activity these cells produced with and without induction of sxy expression.

Results: Of the three fusions I tested (all that I have), one produced almost 100-fold more beta-galactosidase when Sxy was present, one produced only slightly more, and one produced even less! The exclamation mark is because I expected them all to respond similarly.

The fusion that was induced by Sxy is to the ppdA promoter (really the promoter of a 4-gene operon). The H. influenzae homologs (not pilB but comNOPQ) are in a similar operon, which is very strongly induced in competent cells and strongly dependent on CRP and Sxy. The ComN and ComO proteins are known to be required for competence. This fusion is carried on a plasmid. The 100-fold induction when Sxy is overexpressed is what I was hoping to see. This means that the low expression when Sxy is not induced is indeed baseline, so I'm comfortable with this baseline expression not being dependent on Sxy or CRP.

The results with the other fusions are surprising. The one that produced only slightly more is a plasmid-borne fusion of lacZ to the hofM promoter (really the promoter of the hofMNOPQ operon). This is homologous to H. influenzae's comABCDE operon, and like comNOPQ it is required for competence and needs CRP and Sxy for induction. Its CRP-S promoter element doesn't look significantly worse than that of ppdA, but it was induced only three-fold by Sxy overexpression.

The fusion that produced even less beta-galactosidase when Sxy was induced is to the ppdD promoter; it's integrated into the chromosome rather than being carried on a plasmid. This is the most surprising result, as the grad-student-now-postdoc-in-waiting ('gsnpiw') used quantitative PCR to show that ppdD mRNA is induced about 100-fold by overexpression of Sxy from the same plasmid I just used. Induction of Sxy in the fusion-carrying cells not only failed to induce the ppdD::lacZ fusion, it actually made these cells quite sick; the cells with IPTG grew to less than half the density of the uninduced cells, and produced only about half as much beta-galactosidase per cell. Perhaps the chromosomal insertion in these cells has somehow made them sensitive to transcriptional activation of the ppdA gene.

Anyway, the good news is that I can use the ppdA fusion as an indicator of Sxy expression, in my search for conditions that induce Sxy and thus induce expression of CRP-S genes. I'll set aside (for now) the questions about why the other fusions don't behave similarly.

(Sorry I've been too lazy to include figures in my recent blog posts; I promise to improve.)